NCT00831181View on ClinicalTrials.gov

Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Colorectal Cancer
Interventions
DRUG

5-FU

5-FU: continuous infusion via portable pump during all RT (approximately 33 days)

DRUG

Oxaliplatin

Oxaliplatin: 50mg/m2 weekly dosing during RT (Day 1)

DRUG

leucovorin

Folinic Acid (Leucovorin): 400 mg/m2; 2-hour IV infusion simultaneously with oxaliplatin

PROCEDURE

mesorectal excision

mesorectal excision

Trial Locations (2)

10003

Beth Israel Medical Center - Philipps Ambulatory Care Center, New York

10019

St. Luke's-Roosevelt Hospital Center - Roosevelt Division, New York

All Listed Sponsors
lead

Beth Israel Medical Center

OTHER

NCT00831181 - Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer | Biotech Hunter | Biotech Hunter